CASI Pharmaceuticals GAAP EPS of -$0.56, revenue of $8.57M beats by $0.7M
CASI Pharmaceuticals GAAP EPS of -$0.56, revenue of $8.57M beats by $0.7M
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Amphastar Pharmaceuticals Non-GAAP EPS of $0.39 beats by $0.04, revenue of $123.47M beats by $5.59M
SeekingAlpha
-
Ligand Pharmaceuticals Non-GAAP EPS of $1.03 beats by $0.60, revenue of $57.4M beats by $19.67M
SeekingAlpha
-
Reata Pharmaceuticals Non-GAAP EPS of -$1.36 beats by $0.61, revenue of $0.76M misses by $0.7M
SeekingAlpha
-
Amneal Pharmaceuticals Non-GAAP EPS of $0.19 in-line, revenue of $559M beats by $24.56M, revises FY earning guidance
SeekingAlpha